Year: 2013
Type: book-chapter
Abstract: Originally developed for monogenic diseases, and therefore associated with the compensa‐ tion of genes whose alteration is responsible for diseases, the concept of gene therapy has rapidly expanded to the use of DNA as a new type of drug. Therefore, gene therapy leads to indications which are far beyond the case of genetic diseases, since a DNA drug can, in prin‐ ciple, replace any medication which will control protein synthesis. Gene therapy seems an alternative choice to fight against diseases currently treated imperfectly, or not treated with conventional pharmaceutical approaches.
Source: InTech eBooks
DOI: 10.5772/52528
Authors: Aurore Burgain-Chain, Daniel Scherm
Language: English
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W1559978619